Oncolytic virotherapy as immunotherapy.
Oncolytic virotherapy as immunotherapy.
复制标题
DOI:
10.1126/science.abk3436
复制
发表时间:
2021-12-10
期刊:
影响因子:
--
通讯作者:
Vile R
中科院分区:
文献类型:
--
作者:
Melcher A;Harrington K;Vile R
Oncolytic virus (OV) therapy is now something of a misnomer. The initial paradigm was that naturally occurring or genetically engineered viruses would preferentially infect, replicate in, and lyse cancer cells relative to normal cells, leading to selective direct cytotoxicity. The immune system used to be considered detrimental, given its potential to recognize and respond to the virus, prevent its replication, and limit viral spread and tumor cell killing . This view has now been largely replaced by a model in which infection of the tumor by the virus makes it more visible to the immune system for recognition and attack. Tumor cell killing by the virus and/or immune effector cells effectively generates an in situ vaccine, with tumor antigens released into a microenvironment modified by viral infection to reverse tumor-induced immune suppression.
登录
查看更多内容
影响因子:
7.2
作者:
Moehler, M.;Heo, J.;Burke, J. M.
通讯作者:
Burke, J. M.
DOI:
10.1056/nejmoa2024947
发表时间:
2021-04-29
期刊:
The New England journal of medicine
影响因子:
--
作者:
Friedman GK;Johnston JM;Bag AK;Bernstock JD;Li R;Aban I;Kachurak K;Nan L;Kang KD;Totsch S;Schlappi C;Martin AM;Pastakia D;McNall-Knapp R;Farouk Sait S;Khakoo Y;Karajannis MA;Woodling K;Palmer JD;Osorio DS;Leonard J;Abdelbaki MS;Madan-Swain A;Atkinson TP;Whitley RJ;Fiveash JB;Markert JM;Gillespie GY
通讯作者:
Gillespie GY
影响因子:
10.9
作者:
Garcia-Carbonero R;Salazar R;Duran I;Osman-Garcia I;Paz-Ares L;Bozada JM;Boni V;Blanc C;Seymour L;Beadle J;Alvis S;Champion B;Calvo E;Fisher K
通讯作者:
Fisher K
影响因子:
4.7
作者:
Filley AC;Dey M
通讯作者:
Dey M
影响因子:
158.5
作者:
Antonia, S. J.;Villegas, A.;Ozguroglu, M.
通讯作者:
Ozguroglu, M.